✦ LIBER ✦

Liposomal daunorubicin plus cytosine arabinoside for elderly patients with acute myeloid leukemia: The gimema experience

✍ Scribed by M. Vignetti; A. Tafuri; P. Fazi; S. Amadori; A. Camera; F. Ferrara; G. Fioritoni; G. Mariani; L. Pagano; P. Piccaluga; A. Romano; D. Russo; G. Specchia; A. Zaccaria; M. Baccarani; F. Mandelli

Book ID: 114216538
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 20 KB
Volume: 28
Category: Article
ISSN: 0301-472X
DOI: 10.1016/s0301-472x(00)00586-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the southeastern cancer study group

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

Long-term survival and development of se

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial

✍ de Nully Brown, P; Hoffmann, T; Hansen, O P; Boesen, A M; Grønbæk, K; Hippe, E; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

The prognostic significance of leukemic

The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia

✍ Zhijian Xiao; Hua Xue; Rui Li; Li Zhang; Minghua Yu; Yushu Hao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

High-dose homoharringtonine versus stand

High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China

✍ Bin-Tao Huang; Qing-Chun Zeng; Jessica Yu; Xiao-Li Liu; Zhen Xiao; Hong-Qian Zhu 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 346 KB

A homoharringtonine-based induction regi

A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China

✍ Jianmin Wang; Shuqing Lü; Jianmin Yang; Xianmin Song; Li Chen; Chongmei Huang; J 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 359 KB

Low-dose cytosine arabinoside (LD-AraC)

Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group

✍ Zwierzina, H; Suciu, S; Loeffler-Ragg, J; Neuwirtova, R; Fenaux, P; Beksac, M; H 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB